Dataset from Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of cardiovascular disease outcomes.本随机临床试验旨在探究，通过为肾移植受者补充复合维生素以降低其同型半胱氨酸（homocysteine）水平，是否能够减少心血管疾病结局的发生。